$8.02
Today
as of Sep 4, 16:49 ET
Last 30 days
Recent Press Releases & News
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript
Harvard Bioscience, Inc. Q2 2026 Earnings Call Summary
Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ...
Overview
52-week range
$3.80
$9.40
75% of range
Avg surprise (last 1)
+50.0%
Avg reaction (last 2)
-5.8%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.64 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.39 | — | — | -1,850% | -20.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.03 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.02 | — | — | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.02 | $-0.04 | +50.0% | — | +9.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.11 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.07 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.11 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.03 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.02 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.01 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23M | $21M | — | $21M | $20M | $22M | — | $22M |
| Cost of revenue | $10M | $9M | — | $9M | $9M | $10M | — | $9M |
| Gross profit | $13M | $12M | — | $12M | $12M | $12M | — | $13M |
| Operating income | $-978,000 | $-1M | — | $197,000 | $-819,000 | $-50M | — | $-2M |
| Net income | $-3M | $-3M | — | $-1M | $-2M | $-50M | — | $-5M |
| EPS (diluted) | $-0.64 | $-0.77 | — | $-0.03 | $-0.52 | $-11.42 | — | $-0.11 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $7M | $9M | $7M | $7M | $6M | $4M | $5M |
| Inventory | $22M | $22M | $21M | $22M | $22M | $23M | $23M | $26M |
| Total current assets | $46M | $47M | $48M | $44M | $45M | $45M | $45M | $47M |
| Total assets | $76M | $78M | $80M | $78M | $80M | $80M | $127M | $131M |
| Long-term debt | $37M | $36M | $36M | $34M | $35M | $36M | — | $35M |
| Total liabilities | $69M | $68M | $66M | $64M | $64M | $65M | $63M | $66M |
| Total equity | $7M | $10M | $14M | $14M | $16M | $15M | $63M | $65M |
Implied volatility — last 90 days
No IV snapshots yet for HBIO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.